The Institute of Pharmaceutical Research and Technology (IFET S.A.) is a subsidiary of the "National Organization for Medicines" and mainly engages in the production, importation and distribution of pharmaceutical products, which are not marketed in the Greek market by private pharmaceutical companies, but are deemed to be indispensable for patient treatment and the protection of public health. It also engages in other areas of healthcare provision, such as the organization of a safe management system of expired household pharmaceuticals as hazardous waste, as well as the irradiation of medical devices with gamma radiation. The priority of IFET - regardless of the circumstances - is the Patient and the coverage of his/her needs in an integrated and responsible way, with respect to the state and the environment, in line with the applicable legislation, regulations and international standards.
History of foundation: The Institute of Pharmaceutical Research and Technology (Single Member S.A.) is an anonyme company, which was set up in 2000 after the conversion of the Legal person governed by private law. IFET was established in 1991 following the abolition of the then National Pharmaceutical Industry (EF) and the State Pharmaceutical Warehouse (KF). IFET absorbed Pharmetrica in 2001 and ELBIONY in 2009.
Headquarters: IFET headquarters are located in Pallini, Attica (18th km, Marathonos Avenue) as well as a branch office in Magoula, Attica.
President: Konstantina Papakosta
Chief Executive Officer: Eleftheria Tokatlidi
The structure of our company in divisions: